The DOI matches its Crossref record; 35 of the 38 references it cites were found in a registry or an index.
Is freezing in the vaccine cold chain an ongoing issue? A literature review
Open accessAbstract
Vaccine exposure to temperatures below recommended ranges in the cold chain may decrease vaccine potency of freeze-sensitive vaccines leading to a loss of vaccine investments and potentially places children at risk of contracting vaccine preventable illnesses. This literature review is an update to one previously published in 2007 (Matthias et al., 2007), analyzing the prevalence of vaccine exposure to temperatures below recommendations throughout various segments of the cold chain. Overall, 45 studies included in this review assess temperature monitoring, of which 29 specifically assess 'too cold' temperatures. The storage segments alone were evaluated in 41 articles, 15 articles examined the transport segment and 4 studied outreach sessions. The sample size of the studies varied, ranging from one to 103 shipments and from three to 440 storage units. Among reviewed articles, the percentage of vaccine exposure to temperatures below recommended ranges during storage was 33% in wealthier countries and 37.1% in lower income countries. Vaccine exposure to temperatures below recommended ranges occurred during shipments in 38% of studies from higher income countries and 19.3% in lower income countries. This review highlights continuing issues of vaccine exposure to temperatures below recommended ranges during various segments of the cold chain. Studies monitoring the number of events vaccines are exposed to 'too cold' temperatures as well as the duration of these events are needed. Many reviewed studies emphasize the lack of knowledge of health workers regarding freeze damage of vaccines and how this has an effect on temperature monitoring. It is important to address this issue by educating vaccinators and cold chain staff to improve temperature maintenance and supply chain management, which will facilitate the distribution of potent vaccines to children.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of studies have shown that exposure to temperature extremes within vaccine supply chains is relatively common in both developed and developing countries.”
From Using Data to Keep Vaccines Cold in Kenya: Remote Temperature Monitoring With Data Review Teams for Vaccine Management (2019) · cites this paper as [13]
In the citing paper
“Despite the importance of ensuring appropriate temperature ranges for the storage of vaccines throughout the cold chain, relatively few studies have examined the use and effectiveness of temperature monitoring practices or existing studies have found monitoring practices to be substandard, commonly resulting in exposure to temperature extremes.13”
From Using Data to Keep Vaccines Cold in Kenya: Remote Temperature Monitoring With Data Review Teams for Vaccine Management (2019) · cites this paper as [13]
In the citing paper
“As much as 37% of vaccines are exposed to temperatures below the recommended range in lower-income countries, making this a critical issue to address.7–13”
From Using Data to Keep Vaccines Cold in Kenya: Remote Temperature Monitoring With Data Review Teams for Vaccine Management (2019) · cites this paper as [13]
Citations
Cites
Freezing temperatures in the vaccine cold chain: A systematic literature review
Matthias, D. M., Robertson, J., Garrison, M. M., Newland, S., & Nelson, C. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.052 · Cited by 304
Wang, L. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.037002 · Cited by 101
Murhekar, M. V., Dutta, S., Kapoor, A. N., Bitragunta, S., Dodum, R., Ghosh, P., Swamy, K. K., Mukhopadhyay, K., Ningombam, S., Parmar, K., et al. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.13.119974 · Cited by 98
Lloyd, J., Lydon, P., Ouhichi, R., & Zaffran, M. (2015) · Vaccine · doi:10.1016/j.vaccine.2014.10.080 · Cited by 85
Exposure to heat and freezing in the vaccine cold chain in Thailand
Techathawat, S., Varinsathien, P., Rasdjarmrearnsook, A., & Tharmaphornpilas, P. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.09.092 · Cited by 69
Breakwell, L., Moturi, E., Helgenberger, L., Gopalani, S. V., Hales, C. M., Lam, E., Sharapov, U. M., Larzelere, M., Johnson, E., Masao, C., et al. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6438a7 · Cited by 61
McColloster, P., & Vallbona, C. (2011) · American Journal of Public Health · doi:10.2105/ajph.2009.179853 · Cited by 60
Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon
Ateudjieu, J., Kenfack, B., Nkontchou, B. W., & Demanou, M. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-101 · Cited by 59
Lydon, P., Raubenheimer, T., Arnot-Krüger, M., & Zaffran, M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.042 · Cited by 45
Yakum, M. N., Ateudjieu, J., Pélagie, F. R., Walter, E. A., & Watcho, P. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1257-y · Cited by 41
Research works printed but not linked: 2
- Özdemir, 2010, Investigating cold-chain system and efficacy of vaccines reaching the end user in Turkey and related regulations, FABAD J Pharm Sci, 35, 93
- El-Hamadi, 2015, Cold chain status and vaccination activities at vaccination centers in Tripoli, Libya, Hospital, 5, 10
Cited by
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
Wang, J., Peng, Y., Xu, H., Cui, Z., & Williams, R. O. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01744-7 · Cited by 327
Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination
Bruun, T. U. J., Andersson, A.-M. C., Draper, S. J., & Howarth, M. (2018) · ACS Nano · doi:10.1021/acsnano.8b02805 · Cited by 281
Hu, H., Xu, J., Liu, M., & Lim, M. K. (2022) · Journal of Business Research · doi:10.1016/j.jbusres.2022.113480 · Cited by 203
Pambudi, N. A., Sarifudin, A., Gandidi, I. M., & Romadhon, R. (2021) · Energy Reports · doi:10.1016/j.egyr.2021.12.039 · Cited by 194
Neurodevelopmental Disorders and Environmental Toxicants: Epigenetics as an Underlying Mechanism
Tran, N. Q. V., & Miyake, K. (2017) · International Journal of Genomics · doi:10.1155/2017/7526592 · Cited by 192
Metadata
- Authors
- Hanson, C. M., George, A. M., Sawadogo, A., & Schreiber, B.
- Affiliations
- United Nations Children's Fund (US)
- Corresponding author
- Hanson, Celina M.
- ORCID
- Hanson, Celina M.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 35
- Issue
- 17
- Pages
- 2127-2133
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2603215472
- Cited by
- 177
- References
- 38
- Citations by year
- 2026: 20 · 2025: 13 · 2024: 17 · 2023: 22 · 2022: 32 · 2021: 27 · 2020: 25 · 2019: 11 · 2018: 5 · 2017: 5
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Vaccine (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- UNICEF
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Health Professions › Medical Laboratory Technology › Quality and Safety in Healthcare
- Keywords
- vaccine cold chain, vaccine potency, temperature monitoring, vaccine storage, vaccine transport, vaccine supply chain, vaccine-preventable diseases, health professionals' knowledge, vaccine distribution, low-income countries
- MeSH terms
- Drug Storage, Freezing, Humans, Refrigeration, Vaccines, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is freezing in the vaccine cold chain an ongoing issue? A literature review. https://app.cochat.ai/papers/10.1016/j.vaccine.2016.09.070
- The paper
- Hanson, C. M., George, A. M., Sawadogo, A., & Schreiber, B. (2017). Is freezing in the vaccine cold chain an ongoing issue? A literature review. Vaccine. https://doi.org/10.1016/j.vaccine.2016.09.070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.